Implantable Bioartificial Kidney Market Revenue Groth Analysis 2018 To 2026
An implantable bioartificial kidney is similar to existing extracorporeal renal assist device (RAD), which is a bioartificial kidney that combines a membrane hemofilter and a bioreactor to function as a healthy kidney.
An implantable bioartificial kidney is similar to existing extracorporeal renal assist device (RAD), which is a bioartificial kidney that combines a membrane hemofilter and a bioreactor to function as a healthy kidney.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Implantable</strong> <strong>Bioartificial</strong> <strong>Kidney</strong> <strong>Market</strong><br />
<strong>Revenue</strong> <strong>Groth</strong> <strong>Analysis</strong> <strong>2018</strong> <strong>To</strong> <strong>2026</strong><br />
<strong>Implantable</strong> <strong>Bioartificial</strong> <strong>Kidney</strong> <strong>Market</strong>, by End User (Hospitals, Organ<br />
Transplant Centers, and Others), and by Region (North America, Latin America,<br />
Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and<br />
Opportunity <strong>Analysis</strong>, <strong>2018</strong> – <strong>2026</strong><br />
An implantable bioartificial kidney is similar to existing extracorporeal renal assist device<br />
(RAD), which is a bioartificial kidney that combines a membrane hemofilter and a bioreactor to<br />
function as a healthy kidney. However, to work as a natural kidney, the bioartificial kidney<br />
should have high efficiency ultrafiltration membranes, should be able to regulate blood flow,<br />
and stabilize necessary cells. <strong>Implantable</strong> bioartificial kidney is capable of replicating the work<br />
of real kidney and can eliminate the need for dialysis. <strong>Implantable</strong> bioartificial kidney avoids<br />
constant physician oversight and need to take immunosuppressant drugs and medication.<br />
Download PDF Brochure of This Business Research Report :<br />
https://www.coherentmarketinsights.com/insight/request-pdf/2339<br />
<strong>Implantable</strong> <strong>Bioartificial</strong> <strong>Kidney</strong> <strong>Market</strong>: Drivers<br />
Increasing number of chronic kidney disease patients, rising number of kidney failure incidences,<br />
and long waiting list for kidney transplants is expected to boost the global implantable<br />
bioartificial kidney market growth over the forecast period. For instance, according to <strong>Kidney</strong><br />
Health Australia, 2010, the cost of treating all current and new cases of End Stage <strong>Kidney</strong>
Disease (ESKD) will reach up to US$ 12 billion by 2020. Moreover, according to the Centers for<br />
Disease Control & Prevention (CDC), around 15% of the adults in the U.S. were estimated to have<br />
chronic kidney disease in 2017. CDC states that around 96% of the people with kidney damage<br />
or hampered kidney function are not aware of having chronic kidney disease. These factors are<br />
expected to drive the global implantable bioartificial kidney market growth over the forecast<br />
period.<br />
Individual government organizations and manufacturers are working towards increasing the<br />
awareness of kidney diseases. For instance, American <strong>Kidney</strong> Fund (AKF) launched a<br />
comprehensive new kidney disease education portal in May <strong>2018</strong>. The education portal called as<br />
‘CKD Central’ will provide information and resources on chronic kidney disease (CKD). Moreover,<br />
The <strong>Kidney</strong> Project is a national research project, which aims to create a small, surgically<br />
implanted, and free-standing bioartificial kidney to treat end stage renal disease (ESRD). This<br />
kidney is expected to provide ESRD patients with a new option beyond the short-term solution of<br />
renal dialysis and the costly kidney transplant for which donor organs are limited.<br />
<strong>Implantable</strong> <strong>Bioartificial</strong> <strong>Kidney</strong> <strong>Market</strong>: Taxonomy<br />
The global implantable bioartificial kidney market is segmented on the basis of end user, and<br />
region.<br />
By End User:<br />
• Hospitals<br />
• Organ Transplant Centers<br />
• Others<br />
By Region:<br />
• North America<br />
• Latin America<br />
• Europe<br />
• Asia Pacific<br />
• Middle East<br />
• Africa<br />
Request For Customization Of This Business Research Report :<br />
https://www.coherentmarketinsights.com/insight/request-customization/2339<br />
<strong>Implantable</strong> <strong>Bioartificial</strong> <strong>Kidney</strong> <strong>Market</strong>: Regional <strong>Analysis</strong>
North America implantable bioartificial kidney market is expected to hold dominant position in<br />
the global market over the forecast period. According to the National Institute of Diabetes and<br />
Digestive and <strong>Kidney</strong> Diseases (NIDDK), over 661,000 people in the U.S. had kidney failure and of<br />
these, 468,000 individuals were on dialysis, in 2017. The kidney project, headed by researchers<br />
from the University of California San Francisco (UCSF), the University of Vanderbilt, and the<br />
National Institute of Biomedical Imaging and Bioengineering (NIBIB), is expected to receive<br />
approval for the artificial kidney trials by late <strong>2018</strong> or early 2019. These factors are expected to<br />
support the North America implantable bioartificial kidney market growth over the forecast<br />
period. According to report of Brazilian Transplant Registry, 2016, Brazil accounts for the second<br />
largest number of kidney transplant programs in the world.<br />
About Coherent <strong>Market</strong> Insights:<br />
Coherent <strong>Market</strong> Insights is a prominent market research and consulting firm offering actionready<br />
syndicated research reports, custom market analysis, consulting services, and competitive<br />
analysis through various recommendations related to emerging market trends, technologies, and<br />
potential absolute dollar opportunity.<br />
Contact Us:<br />
Mr. Shah<br />
Coherent <strong>Market</strong> Insights<br />
1001 4th Ave, #3200<br />
Seattle, WA 98154<br />
Tel: +1–206–701–6702<br />
Email: sales@coherentmarketinsights.com<br />
Visit Our New Website : https://www.coherentwire.com